Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    " June 26, 2013":" July 26, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" June 26, 2013":" July 26, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People
Condition: HIV Positive
Intervention:
2 Unknown  Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread?
Condition: HIV Infection
Intervention: Other: Blood sample
3 Recruiting A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL)
Condition: HIV Infection
Interventions: Drug: abacavir/lamivudine + raltegravir;   Drug: abacavir/lamivudine + darunavir/ritonavir
4 Active, not recruiting Oligonucleotide Ligation Assay (OLA) Resistance Study
Condition: HIV Positive
Intervention: Other: Pre-ART Oligonucleotide Assay (OLA)
5 Active, not recruiting Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa
Condition: HIV Infection
Interventions: Drug: monoPI - boosted lopinavir or boosted darunavir;   Drug: bi therapy - (boosted lopinavir or boosted darunavir) + lamivudine
6 Withdrawn Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV Medications
Condition: HIV Infections
Interventions: Biological: GEO-D03 DNA Vaccine;   Biological: MVA/HIV62B Vaccine;   Biological: Placebo for DNA GEO-D03;   Biological: Placebo for MVA/HIV62B Vaccine
7 Completed Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique
Condition: HIV-positive
Intervention: Behavioral: SMS reminders
8 Recruiting Switch to Maraviroc + Integrase Inhibitor
Condition: HIV
Intervention: Drug: Switch to Maraviroc + Raltegravir or Dolutegravir
9 Completed An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 Infection
Condition: HIV Infections
Intervention:
10 Active, not recruiting Integrating ENGagement and Adherence Goals Upon Entry iENGAGE to Control HIV
Condition: HIV
Intervention: Behavioral: Based on behavioral motivational interviewing (MI) technique
11 Completed Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients
Condition: Hiv Infection
Intervention: Biological: blood sampling,
12 Completed Juvenile Detention to Community Life
Conditions: Substance Use;   Delinquency;   Risk for HIV Infection
Interventions: Behavioral: Multidimensional Family Therapy Cross-Systems;   Behavioral: Enhanced Services as Usual
13 Active, not recruiting Link4Health: A Combination Strategy for Linkage and Retention, Swaziland
Condition: HIV (Human Immunodeficiency Virus)
Interventions: Procedure: POC (point-of-care) CD4+ (cluster of differentiation 4) Count;   Procedure: Accelerated ART (antiretroviral therapy) Initiation;   Behavioral: Basic Care and Prevention Package;   Behavioral: Cellular Appointment Reminders and Follow-Up;   Other: Financial Incentive
14 Recruiting Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
Conditions: HIV Infection;   Osteopenia
Interventions: Drug: raltegravir and atazanavir and ritonavir;   Drug: tenofovir/emtricitabine and atazanavir and ritonavir
15 Enrolling by invitation Multi-component HIV Intervention Packages for Chinese Men Who Have Sex With Men —Test, Link and Care (TLC)
Condition: HIV/AIDS
Intervention: Behavioral: Enhancing HIV testing
16 Completed Sustainable HIV Risk Reduction Strategies for CJ Systems
Condition: HIV Risk Behaviors
Intervention: Behavioral: WaySafe
17 Completed Mfangano Island Healthy Networks Impact Study
Condition: HIV
Intervention: Behavioral: Mfangano Health Net Microclinic Program
18 Active, not recruiting Swaziland Safe Generations
Condition: HIV/AIDS
Intervention: Other: Option B+
19 Completed Male Engagement in PMTCT Services
Condition: HIV
Interventions: Other: clinic based intervention;   Other: clinic and community based intervention
20 Active, not recruiting Same-Day HIV Testing and Treatment Initiation to Improve Retention in Care
Condition: HIV
Interventions: Other: Same-Day HIV testing and ART initiation;   Other: Standard ART Initiation;   Other: Sub-Study: Same-Day ART, CD4 Count >500;   Other: Sub-Study: Standard Pre-ART Care, CD4 Count >500

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.